ClinicalTrials.Veeva

Menu

Feasibility Study of a Systematic Approach for Deprescribing of Statins and PPI's. (FeDeS+P)

Z

Zuyderland Medisch Centrum

Status

Completed

Conditions

Polypharmacy

Treatments

Other: Deprescribing algorithm

Study type

Interventional

Funder types

Other

Identifiers

NCT04204590
Z2018001

Details and patient eligibility

About

Deprescribing, the process of safely reducing or discontinuing unnecessary or harmful medication, has the potential to decrease polypharmacy and improve health outcomes. In this study a structured implicit algorithm, focusing on both extrinsic medication factors (eg change in disease) and intrinsic patient factors (eg. pill burden) will be used.

Enrollment

75 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Participant uses a statin and/or a proton pump inhibitor.
  • Participant signs informed consent.
  • Participant is a nursing home resident.

Exclusion criteria

  • Participant is there for short term nursing home admission (<3 months)
  • Participant is there for hospice admission.

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

75 participants in 1 patient group

Participants
Other group
Description:
The aim of this study is to test the feasibility of this algorithm as an intervention to carry out deprescribing a targeted medication group, proton pump inhibitors (PPI's) and statins, among nursing home residents.
Treatment:
Other: Deprescribing algorithm

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems